104 related articles for article (PubMed ID: 17974288)
1. Increased Tim-3
Kato R; Yamasaki M; Urakawa S; Nishida K; Makino T; Morimoto-Okazawa A; Kawashima A; Iwahori K; Suzuki S; Ueda R; Mori M; Satoh T; Doki Y; Wada H
Cancer Immunol Immunother; 2018 Nov; 67(11):1673-1683. PubMed ID: 30128737
[TBL] [Abstract][Full Text] [Related]
2. Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis.
Song GM; Tian X; Liu XL; Chen H; Zhou JG; Bian W; Chen WQ
Oncotarget; 2017 Jun; 8(23):37963-37973. PubMed ID: 28415814
[TBL] [Abstract][Full Text] [Related]
3. Phase II multicenter trial: first-line immunochemotherapy with or without radiotherapy in metastatic esophageal squamous cell cancer (SCR-ESCC-01).
Li Y; Lin L; Liu J; Cai XW; Zhang Q; Song XY; Zhao SG; Ma XM; Fu XL; Yu W
Future Oncol; 2023 Nov; 19(34):2291-2296. PubMed ID: 37937444
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study.
Lyu J; Li T; Wang Q; Li F; Diao P; Liu L; Li C; Lang J
Radiat Oncol; 2018 Nov; 13(1):233. PubMed ID: 30477531
[TBL] [Abstract][Full Text] [Related]
5. Cyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma.
Huang JX; Shen SL; Lin M; Xiao W; Chen WC; Lin MS; Yu H; Chen P; Qian RY
Oncol Lett; 2012 Oct; 4(4):607-611. PubMed ID: 23205070
[TBL] [Abstract][Full Text] [Related]
6. [Combined radiotherapy and pre-radiation chemotherapy with cisplatin and 5-fluorouracil for advanced esophageal carcinoma. II. Clinical evaluation in cases with higher than T2 stage].
Sueyama H
Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1608-18. PubMed ID: 2230444
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.
Zhang X; Shen L; Li J; Li Y; Li J; Jin M
Am J Clin Oncol; 2008 Feb; 31(1):29-33. PubMed ID: 18376224
[TBL] [Abstract][Full Text] [Related]
8. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
9. [Phase II study of paclitaxel and cisplatin for advanced squamous-cell carcinoma of esophagus].
Huang J; Cai RG; Meng PJ; Zhang MJ; Cui CX; Yang L; Chu DT; Sun Y; Wang JW
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):753-5. PubMed ID: 15733398
[TBL] [Abstract][Full Text] [Related]
10. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
11. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
12. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study.
Kumar L; Kaushal R; Nandy M; Biswal BM; Kumar S; Kriplani A; Singh R; Rath GK; Kochupillai V
Gynecol Oncol; 1994 Sep; 54(3):307-15. PubMed ID: 7522200
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
